+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of intracerebral infusion of excitatory amino acid antagonist 2 amino 5 phosphonovaleric acid ap5 on the timing of puberty in the rat



Effect of intracerebral infusion of excitatory amino acid antagonist 2 amino 5 phosphonovaleric acid ap5 on the timing of puberty in the rat



Journal of Endocrinology 124(Suppl.)




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031091442

Download citation: RISBibTeXText


Related references

Studies with excitatory amino acid antagonists in rat CNS: 2-amino-5-phosphonovaleric acid, phenytoin, and benzodiazepines. Advances in Biochemical Psychopharmacology 29: 223-230, 1981

Free amino acid patterns of serum of the patients with gastric cancer, especially on their control by infusions of amino acid solution. Effect of infusion of amino acid mixture on plasma free amino acids following gastrectomy. Sapporo Igaku Zasshi. Sapporo Medical Journal 35(1): 39-66, 1969

The excitatory amino acid antagonist amino-phosphono-valeric acid (APV) provides protection against penicillin-induced epileptic activity in the rat. Epilepsy Research 6(3): 249-251, 1990

Protection against morphine induced explosive motor behavior by the excitatory amino acid antagonist 2 amino 7 phosphoheptanoic acid. Society for Neuroscience Abstracts 13(2): 1306, 1987

Ionotropic excitatory amino acid receptor ligands. Synthesis and pharmacology of a new amino acid AMPA antagonist. European Journal of Medicinal Chemistry 35(1): 69-76, 2000

The excitatory amino acid receptor antagonist 2 amino 7 phosphonoheptanoic acid produces anticonflict activity. Society for Neuroscience Abstracts 11(1): 106, 1985

The excitatory amino acid antagonist amino-phosphonobutyric acid (APB) changes the cat retinal ganglion cell activity evoked by eyeball deformation or light flashes. Behavioural Brain Research 26(2-3): 221-221, 1987

Excitatory amino acid agonist-antagonist interactions at 2-amino-4-phosphonobutyric acid-sensitive quisqualate receptors coupled to phosphoinositide hydrolysis in slices of rat hippocampus. Journal of Neurochemistry 50(5): 1605-1613, 1988

N-Methyl-DL-Aspartate Receptor Antagonism by D-2-Amino-5-Phosphonovaleric Acid Delays Onset of Puberty in the Female Rat. Journal of Neuroendocrinology 2(5): 627-631, 1990

The anticonvulsant potency of (+/-)-2-Amino-7-phosphonoheptanoic acid and (+/-)-2-amino-5-phosphonovaleric acid against metaphit-induced audiogenic seizures in rats. Pharmacological Research 38(5): 347-351, 1998

Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. Journal Of Infectious Diseases. 173(1): 166-171, 1996

Non-competitive regulation of phencyclidine/-receptors by the receptor antagonist d-()-2-amino-5-phosphonovaleric acid. Neuroscience Letters 78(2): 193-198, 1987

Phencyclidine-like catalepsy induced by the excitatory amino acid antagonist DL-2-amino-5-phosphonovalerate. Behavioural Brain Research 19(3): 257-259, 1986

2 amino 6 trifluoromethoxybenzothiazole a possible antagonist of excitatory amino acid neurotransmission 1. anticonvulsant properties. Neuropharmacology 24(8): 767-774, 1985

Behavioural and EEG changes induced by 2-amino-7-phosphonoheptanoic acid and 2-amino-5-phosphonovaleric acid. Medical Science Research 26(4): 239-240, 1998